PS
Parminder Singh
About Parminder Singh
Data last updated:
Parminder Singh is a Director at Ankran Biotech Private Limited (since 2016), Director at Vexxon Overseas Limited (since 2023) and Director at Amkon Pharmaceuticals Private Limited (since 2021). The companies operate in Pharma and Paper. The largest current company by reported revenue is Ankran Biotech Private Limited at ₹8.91 Cr (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Mar 2016 | 2016 | ₹8.91 Cr (FY 2021) | Active | |
| Director | 30 Nov 2023 | 2023 | Active | ||
| Director | 10 May 2021 | 2021 | Active |
Board colleagues of Parminder Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anjali | 08184743 | Ankran Biotech Private Limited , Vexxon Overseas Limited and 1 more | Director |
| Sandeep Sharma | 08329899 | Vexxon Overseas Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Parminder Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parminder Singh
Parminder Singh currently holds 3 directorships: Ankran Biotech Private Limited (Director, since 01 Mar 2016, revenue ₹8.91 Cr (FY 2021)); Vexxon Overseas Limited (Director, since 30 Nov 2023); Amkon Pharmaceuticals Private Limited (Director, since 10 May 2021).
Parminder Singh was first appointed on 01 Mar 2016 as Director at Ankran Biotech Private Limited. The most recent appointment on record is 30 Nov 2023 at Vexxon Overseas Limited.
The current boards of Parminder Singh's companies include Anjali (Ankran Biotech Private Limited), Sandeep Sharma (Vexxon Overseas Limited).